{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:02Z","timestamp":1761630362030},"reference-count":27,"publisher":"Wiley","issue":"11-12","license":[{"start":{"date-parts":[[2004,12,6]],"date-time":"2004-12-06T00:00:00Z","timestamp":1102291200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Proton\u2010pump inhibitors are often recommended for continuous use in gastro\u2010oesophageal reflux disease, but this may not be necessary in all patients.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To ascertain the level of evidence for alternative strategies for proton\u2010pump inhibitor treatment in gastro\u2010oesophageal reflux disease.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002We searched for observational or interventional studies examining alternatives to continuous proton\u2010pump inhibitor treatment in gastro\u2010oesophageal reflux disease.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Non\u2010randomized studies suggest that some patients with gastro\u2010oesophageal reflux disease, including some with erosive oesophagitis, may be adequately maintained on proton\u2010pump inhibitor therapy given less frequently than once daily. However, the results may not be generalizable. Four high quality randomized\u2010controlled trials compared \u2018on\u2010demand\u2019 proton\u2010pump inhibitor and placebo treatment in endoscopy\u2010negative reflux disease; all found this effective for most patients. One high quality randomized\u2010controlled trial found intermittent courses of a proton\u2010pump inhibitor or H<jats:sub>2<\/jats:sub>\u2010receptor antagonist in erosive oesophagitis or endoscopy\u2010negative reflux disease adequate for almost half of the patients studied. Up to 80% of patients on continuous high\u2010dose proton\u2010pump inhibitor treatment for gastro\u2010oesophageal reflux disease can be \u2018stepped down\u2019 to less intensive therapy.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002On\u2010demand proton\u2010pump inhibitor treatment may be appropriate in endoscopy\u2010negative reflux disease. In gastro\u2010oesophageal reflux disease, patients taking more than once daily or high\u2010dose proton\u2010pump inhibitor treatment, a step down to once daily or standard dose therapy should be attempted.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02289.x","type":"journal-article","created":{"date-parts":[[2004,12,10]],"date-time":"2004-12-10T13:26:26Z","timestamp":1102685186000},"page":"1241-1251","source":"Crossref","is-referenced-by-count":38,"title":["Systematic review: is there excessive use of proton pump inhibitors in gastro\u2010oesophageal reflux disease?"],"prefix":"10.1111","volume":"20","author":[{"given":"T. J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. B.","family":"Fennerty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W.","family":"Howden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,12,6]]},"reference":[{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.155.14.1465"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1803"},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"e_1_2_14_5_2","first-page":"451","article-title":"Long\u2010term prescribing of proton pump inhibitors in general practice","volume":"49","author":"Hungin APS","year":"1999","journal-title":"Br J Gen Pract"},{"key":"e_1_2_14_6_2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1742-1241.2000.tb11906.x","article-title":"Cost\u2010effective prescribing of proton pump inhibitor therapy: an audit in general practice","volume":"54","author":"Cooper AL","year":"2000","journal-title":"Int J Clin Pract"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03861.x"},{"key":"e_1_2_14_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.28649"},{"key":"e_1_2_14_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07665.x"},{"key":"e_1_2_14_10_2","first-page":"263","article-title":"A practice\u2010based approach for converting from proton pump inhibitors to less costly therapy","volume":"4","author":"Lucas LM","year":"2001","journal-title":"Eff Clin Pract"},{"key":"e_1_2_14_11_2","first-page":"485","article-title":"Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro\u2010oesophageal reflux disease","volume":"16","author":"St\u00e5lhamar N\u2010O","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200208000-00008"},{"key":"e_1_2_14_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01999.x"},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7182.502"},{"key":"e_1_2_14_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00564.x"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00943.x"},{"key":"e_1_2_14_17_2","first-page":"607","article-title":"On demand therapy for Los Angeles grade A and B reflux esophagitis: esomeprazole versus omeprazole","volume":"102","author":"Kao A\u2010W","year":"2003","journal-title":"J Formos Med Assoc"},{"key":"e_1_2_14_18_2","first-page":"A50","article-title":"Esomeprazole continuous versus on\u2010demand maintenance therapy in 1052 gastro\u2010oesophageal reflux disease patients: similar satisfaction but superior quality of life for once daily treatment","volume":"15","author":"Engels LGJB","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_14_19_2","first-page":"A\u2010338","article-title":"The economical impact of six months management of gastroesophageal reflux disease in primary care: comparison between on\u2010demand treatment and treatment courses with esomeprazole","volume":"126","author":"Meineche\u2010Schmidt W","year":"2004","journal-title":"Gastroenterology"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18224"},{"key":"e_1_2_14_21_2","first-page":"A165","article-title":"Can we predict which patients with severe gastroesophageal reflux disease will tolerate alternate day therapy with omeprazole","volume":"110","author":"Kurucar C","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_14_22_2","first-page":"A35","article-title":"Alternate day omeprazole maintenance therapy in H2RA\u2010resistant esophagitis \u2013 clinical, gastrin and ECL cell effects for up to three years","volume":"102","author":"Bank S","year":"1992","journal-title":"Gastroenterology"},{"key":"e_1_2_14_23_2","first-page":"A38","article-title":"\u2018Spaced\u2019 omeprazole dosing in maintenance therapy of H2RA resistant reflux esophagitis \u2013 results from 6\u201348\u2003months","volume":"104","author":"Bank S","year":"1993","journal-title":"Gastroenterology"},{"key":"e_1_2_14_24_2","first-page":"A64","article-title":"Daily or intermittent omeprazole in the long\u2010term treatment of erosive esophagitis: results after 2\u20138\u2003years of continuous therapy","volume":"112","author":"Bank S.","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_14_25_2","first-page":"A173","article-title":"Maintenance treatment of severely complicated reflux esophagitis with low dose of omeprazole","volume":"35","author":"Mantides A","year":"1994","journal-title":"Gut"},{"key":"e_1_2_14_26_2","first-page":"A136","article-title":"Gastroesophageal reflux on daily vs. alternate day omeprazole","volume":"106","author":"Mehta V","year":"1994","journal-title":"Gastroenterology"},{"key":"e_1_2_14_27_2","first-page":"A189","article-title":"Alternate day omeprazole maintenance therapy for grade 2\u20133 reflux esophagitis","volume":"112","author":"Ladas SD","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_14_28_2","first-page":"A189","article-title":"Criteria for alternate day omeprazole maintenance therapy in patients with grade 2\u20133 reflux esophagitis","volume":"112","author":"Ladas SD","year":"1997","journal-title":"Gastroenterology"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02289.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02289.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02289.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T18:34:48Z","timestamp":1693420488000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02289.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":27,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02289.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02289.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}